Tempus AI, Inc., a leader in artificial intelligence and precision medicine, today announced the clinical launch of the ArteraAI Prostate Test (mHSPC). The CLIA-certified and CAP-accredited prognostic ...
TEM is integrating externally developed AI pathology into its ecosystem to improve risk prediction and personalize prostate ...
A new blood test could help doctors identify whether a treatment for advanced prostate cancer is failing weeks earlier than ...
Add Yahoo as a preferred source to see more of our stories on Google. PSA stands for prostate-specific antigen, a substance naturally produced in prostate tissue. A small amount of PSA regularly ...
To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...
Health-evidence reviewers reverse recommendation on a blood test that detects a biomarker of a common cancer after decades of ...
3d
Doctors may have found an easier way to treat prostate cancer — could become new ‘standard of care’
A new study may have found a potentially easier, less disruptive and more effective way to treat the second leading cause of ...
A new urine test performed better than PSA-based testing and MRI for monitoring low-risk prostate cancers on active ...
Prostate-specific antigen (PSA) blood testing likely reduces the risk of death from prostate cancer, found a new review ...
WASHINGTON D.C. (WPVI) -- The Preventive Services Task Force is changing recommendations that can affect millions of middle-aged men. Five years ago, it opposed routine screening for prostate cancer, ...
At-home cancer tests are a great way to learn key information about your health without having to visit the doctor in person. This option is good for patients who don’t have time to go to the doctor’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results